Patients Pregnant Women With or Without Primary Antiphospholipid Antibody Syndrome
Recruiting
Observational Study
Preeclampsia
Immunologic Disease
Antiphospholipid Antibody Syndrome Primary
Pregnancy Complications
Pregnancy, High Risk
Rheumatic Diseases
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 45
- Sex
- Female
- Study type
- Observational
- Participants needed
- 60 (estimated)
- Sponsor
- IRCCS San Raffaele · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of the study is to evaluate the ability of placental angiogenesis markers to predict the risk of PE in pregnancy in women with primary APS.
To construct reference intervals of placental angiogenesis markers specific to women affected by primary APS in pregnancy by measuring the levels of sFlt-1and PlGF in serum maternal serum and their sFlt-1/PlGF ratio during the trimesters of gestat…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Group 1
1. Pregnant patients between the ages of 18 and 45 years.
2. Diagnosis of primary APS, according to international classification criteria.
* Group 2
1. Pregnant patients between the ages of 18 and 45 years.
2. Patients with at least one previous full-term pre…
Contacts